Matthieu Mahévas - Chaires d’excellence en Biologie Santé de France 2030
L'INEM se félicite de la sélection de Matthieu Mahévas parmi les lauréats de l’appel à projets « Chaires d'Excellence en Biologie-Santé » dans le cadre de l'initiative France 2030.
Le dispositif Chaire d’excellence en Biologie-Santé, un programme ambitieux de l'Agence Nationale de la Recherche, a pour objectif d’offrir à des chercheurs de premier plan et de toutes origines des financements conséquents pour mener en France de nouveaux projets d’envergure sur une durée de 5 ans.
Marcelle Machluf
Marcelle Machluf received her Ph.D. in Biotechnology Engineering from Ben-Gurion University (Israel), and then went on to complete a 5-year post-doctoral fellowship at the Harvard Medical School under the supervision of distinguished scholars Robert Langer and Anthony Atalla. During these years, she gained extensive hands-on experience with biomaterials and the development of biomedical platforms.
Georg Halder
Georg Halder is Professor at the University of Leuven and the Flemish Institute for Biotechnology (VIB) in Belgium. He earned his Ph.D. in 1996 from the University of Basel in Switzerland under the guidance of Walter Gehring and was a postdoctoral fellow with Sean Carroll at the University of Wisconsin in Madison, USA. Prior to his current position, he was a faculty member at the MD Anderson Cancer Center in Houston Texas (2000-2012).
Svetoslav Chakarov
Svetoslav Chakarov received his doctorate in immunology from Paul Sabatier University of Toulouse, France under the guidance of Professor Nicolas Fazilleau. He then joined Florent Ginhoux’s research team in Singapore Immunology Network as postdoctoral fellow. After concluding his postdoctoral training in 2020 he joined Shanghai Institute of Immunology, Shanghai Jiao Tong University School of Medicine as principal investigator and is currently head of “Myeloid cell biology and metabolism” laboratory.
Oliver Florey
Oliver Florey completed his Ph.D at Imperial College London in 2006, with Prof. Dorian Haskard, studying the recruitment of leukocytes to sites of inflammation. He followed this with a post-doc in the lab of Prof. Bill Muller at Weill Cornell Medical College in New York, and another with Dr Micheal Overholtzer at Memorial Sloan Kettering Cancer Center, New York. In 2014 he was awarded a Cancer Research UK Career Development award to start my own lab at the Babraham Institute, Cambridge, UK.
Pagination
- Première page
- Page précédente
- …
- 36
- 37
- 38
- 39
- 40
- 41
- 42
- 43
- 44
- …
- Page suivante
- Dernière page